- Home
- ZLAB vs BKV Comparison
ZLAB vs BKV Comparison
Compare ZLAB & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | BKV |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2017 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | BKV |
|---|---|---|
| Price | $26.49 | $23.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $49.60 | $34.22 |
| AVG Volume (30 Days) | 781.7K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.46 | ★ 199.00 |
| EPS | N/A | ★ 1.11 |
| Revenue | $460,156,000.00 | ★ $893,781,000.00 |
| Revenue This Year | $9.75 | $69.39 |
| Revenue Next Year | $26.03 | $9.45 |
| P/E Ratio | ★ N/A | $20.68 |
| Revenue Growth | 15.33 | ★ 47.85 |
| 52 Week Low | $15.96 | $20.08 |
| 52 Week High | $34.72 | $32.81 |
Technical Indicators
Market Signals| Indicator | ZLAB | BKV |
|---|---|---|
| Relative Strength Index (RSI) | 62.61 | 38.69 |
| Support Level | $16.84 | N/A |
| Resistance Level | $27.22 | $27.55 |
| Average True Range (ATR) | 0.88 | 0.97 |
| MACD | -0.05 | -0.23 |
| Stochastic Oscillator | 80.44 | 9.05 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About BKV BKV Corporation
BKV Corp is a growth-driven energy company focused on the development of natural gas-producing assets, the ownership and operation of natural gas-fired power generation assets, and selective accretive acquisitions. The company's core businesses are the production of natural gas and the generation of natural gas-fired power from its owned and operated assets, supported by a closed-loop plan, enabled by its upstream, midstream, power, and CCUS businesses.